Israel Englander Ocular Therapeutix, Inc Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Millennium Management LLC holds 169,331 shares of OCUL stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169,331

Previous 775,167 78.16%

Holding current value

$1.16 Million

Previous $3.46 Million 55.45%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.85 - $10.93 $2.33 Million - $6.62 Million	-605,836 Reduced 78.16%	169,331 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $3.37 Million - $7.33 Million	-1,621,673 Reduced 67.66%	775,167 $3.46 Million
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $6.26 Million - $10.4 Million	1,360,285 Added 131.23%	2,396,840 $12.4 Million
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $2.68 Million - $6.01 Million	959,233 Added 1240.57%	1,036,555 $5.46 Million
Q4 2022 Feb 14, 2023	SELL	$2.61 - $4.41 $322,992 - $545,746	-123,752 Reduced 61.55%	77,322 $217,000

Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $605,839 - $962,825	-148,127 Reduced 42.42%	201,074 $834,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $1.16 Million - $2.02 Million	-386,532 Reduced 52.54%	349,201 $1.4 Million
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $2.14 Million - $3.26 Million	443,541 Added 151.8%	735,733 $3.64 Million
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $67,224 - $131,719	10,913 Added 3.88%	292,192 $2.04 Million
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $2.58 Million - $3.82 Million	266,135 Added 1757.36%	281,279 $2.81 Million
Q2 2021 Aug 16, 2021	SELL	$13.43 - $19.16 $2.41 Million - $3.43 Million	-179,151 Reduced 92.21%	15,144 $215,000
Q1 2021 May 17, 2021	BUY	$15.82 - $22.11 $3.07 Million - $4.3 Million	194,295 New	194,295 $3.19 Million
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $1.5 Million - $4.34 Million	-189,007 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.36 - $9.87 $1.22 Million - $1.63 Million	165,570 Added 706.45%	189,007 $1.44 Million
Q2 2020 Aug 14, 2020	SELL	$4.67 - $8.95 $4.64 Million - $8.88 Million	-992,639 Reduced 97.69%	23,437 $195,000
Q1 2020 May 14, 2020	BUY	$3.95 - $7.4 $3.87 Million - $7.25 Million	979,183 Added 2654.12%	1,016,076 $5.03 Million
Q4 2019 Feb 14, 2020	BUY	$2.57 - $4.73 $94,815 - $174,503	36,893 New	36,893 $146,000
Q1 2019 May 14, 2019	SELL	$3.51 - $4.77 $738,058 - $1 Million	-210,273 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.87 - $7.11 $193,956 - $356,338	50,118 Added 31.29%	210,273 $837,000
Q3 2018 Nov 14, 2018	BUY	$5.42 - $6.99 $868,040 - $1.12 Million	160,155 New	160,155 $1.1 Million
Q2 2018 Aug 14, 2018	SELL	$5.99 - $8.17 $253,790 - $346,154	-42,369 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.66 - $7.08 $94,094 - $142,959	20,192 Added 91.05%	42,369 $276,000
Q4 2017 Feb 14, 2018	BUY	$3.73 - $6.37 $34,151 - $58,323	9,156 Added 70.32%	22,177 $99,000
Q3 2017 Nov 14, 2017	BUY	$5.28 - $6.88 $68,750 - $89,584	13,021	13,021 $80,000

Others Institutions Holding OCUL

# of Institutions

148

Shares Held

123M

Call Options Held

185K

Put Options Held

507K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account